Journal of Medicinal Chemistry, volume 60, issue 16, pages 7108-7122

Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery

Azzali Elisa 1
Machado Diana 2
Kaushik Amit Kant 3, 4
Vacondio Federica 5
Flisi Sara 6
Cabassi Clotilde Silvia 6
Lamichhane Gyanu 3, 4
Viveiros Miguel 2
Costantino Gabriele 5
Pieroni Marco 5
Publication typeJournal Article
Publication date2017-08-10
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor7.3
ISSN00222623, 15204804
Drug Discovery
Molecular Medicine
Abstract
Tuberculosis remains one of the deadliest infectious diseases in the world, and the increased number of multidrug-resistant and extremely drug-resistant strains is a significant reason for concern. This makes the discovery of novel antitubercular agents a cogent priority. We have previously addressed this need by reporting a series of substituted 2-aminothiazoles capable to inhibit the growth of actively replicating, nonreplicating persistent, and resistant Mycobacterium tuberculosis strains. Clues from the structure-activity relationships lining up the antitubercular activity were exploited for the rational design of improved analogues. Two compounds, namely N-phenyl-5-(2-(p-tolylamino)thiazol-4-yl)isoxazole-3-carboxamide 7a and N-(pyridin-2-yl)-5-(2-(p-tolylamino)thiazol-4-yl)isoxazole-3-carboxamide 8a, were found to show high inhibitory activity toward susceptible M. tuberculosis strains, with an MIC90 of 0.125-0.25 μg/mL (0.33-0.66 μM) and 0.06-0.125 μg/mL (0.16-0.32 μM), respectively. Moreover, they maintained good activity also toward resistant strains, and they were selective over other bacterial species and eukaryotic cells, metabolically stable, and apparently not susceptible to the action of efflux pumps.

Citations by journals

1
2
3
4
5
6
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 6, 10%
European Journal of Medicinal Chemistry
6 publications, 10%
Molecules
Molecules, 2, 3.33%
Molecules
2 publications, 3.33%
Polycyclic Aromatic Compounds
Polycyclic Aromatic Compounds, 2, 3.33%
Polycyclic Aromatic Compounds
2 publications, 3.33%
Pharmaceuticals
Pharmaceuticals, 2, 3.33%
Pharmaceuticals
2 publications, 3.33%
Medicinal Chemistry Research
Medicinal Chemistry Research, 2, 3.33%
Medicinal Chemistry Research
2 publications, 3.33%
Journal of Molecular Structure
Journal of Molecular Structure, 2, 3.33%
Journal of Molecular Structure
2 publications, 3.33%
Journal of Saudi Chemical Society
Journal of Saudi Chemical Society, 2, 3.33%
Journal of Saudi Chemical Society
2 publications, 3.33%
Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters, 2, 3.33%
Bioorganic and Medicinal Chemistry Letters
2 publications, 3.33%
Bioorganic Chemistry
Bioorganic Chemistry, 2, 3.33%
Bioorganic Chemistry
2 publications, 3.33%
Journal of Organic Chemistry
Journal of Organic Chemistry, 2, 3.33%
Journal of Organic Chemistry
2 publications, 3.33%
RSC Advances
RSC Advances, 2, 3.33%
RSC Advances
2 publications, 3.33%
Journal of Antibiotics
Journal of Antibiotics, 1, 1.67%
Journal of Antibiotics
1 publication, 1.67%
Combinatorial Chemistry and High Throughput Screening
Combinatorial Chemistry and High Throughput Screening, 1, 1.67%
Combinatorial Chemistry and High Throughput Screening
1 publication, 1.67%
Archiv der Pharmazie
Archiv der Pharmazie, 1, 1.67%
Archiv der Pharmazie
1 publication, 1.67%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 1, 1.67%
Journal of Medicinal Chemistry
1 publication, 1.67%
Organic and Biomolecular Chemistry
Organic and Biomolecular Chemistry, 1, 1.67%
Organic and Biomolecular Chemistry
1 publication, 1.67%
Anti-Infective Agents
Anti-Infective Agents, 1, 1.67%
Anti-Infective Agents
1 publication, 1.67%
Mini-Reviews in Organic Chemistry
Mini-Reviews in Organic Chemistry, 1, 1.67%
Mini-Reviews in Organic Chemistry
1 publication, 1.67%
Future Medicinal Chemistry
Future Medicinal Chemistry, 1, 1.67%
Future Medicinal Chemistry
1 publication, 1.67%
Frontiers in Microbiology
Frontiers in Microbiology, 1, 1.67%
Frontiers in Microbiology
1 publication, 1.67%
Nature Reviews Chemistry
Nature Reviews Chemistry, 1, 1.67%
Nature Reviews Chemistry
1 publication, 1.67%
Molecular Diversity
Molecular Diversity, 1, 1.67%
Molecular Diversity
1 publication, 1.67%
BMC Chemistry
BMC Chemistry, 1, 1.67%
BMC Chemistry
1 publication, 1.67%
Organic Letters
Organic Letters, 1, 1.67%
Organic Letters
1 publication, 1.67%
Tetrahedron
Tetrahedron, 1, 1.67%
Tetrahedron
1 publication, 1.67%
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, 1, 1.67%
Bioorganic and Medicinal Chemistry
1 publication, 1.67%
ChemMedChem
ChemMedChem, 1, 1.67%
ChemMedChem
1 publication, 1.67%
Asian Journal of Organic Chemistry
Asian Journal of Organic Chemistry, 1, 1.67%
Asian Journal of Organic Chemistry
1 publication, 1.67%
Advanced Synthesis and Catalysis
Advanced Synthesis and Catalysis, 1, 1.67%
Advanced Synthesis and Catalysis
1 publication, 1.67%
1
2
3
4
5
6

Citations by publishers

2
4
6
8
10
12
14
16
18
Elsevier
Elsevier, 17, 28.33%
Elsevier
17 publications, 28.33%
Springer Nature
Springer Nature, 6, 10%
Springer Nature
6 publications, 10%
Wiley
Wiley, 6, 10%
Wiley
6 publications, 10%
American Chemical Society (ACS)
American Chemical Society (ACS), 6, 10%
American Chemical Society (ACS)
6 publications, 10%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 5, 8.33%
Royal Society of Chemistry (RSC)
5 publications, 8.33%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 4, 6.67%
Multidisciplinary Digital Publishing Institute (MDPI)
4 publications, 6.67%
Taylor & Francis
Taylor & Francis, 4, 6.67%
Taylor & Francis
4 publications, 6.67%
Bentham Science
Bentham Science, 3, 5%
Bentham Science
3 publications, 5%
Pleiades Publishing
Pleiades Publishing, 3, 5%
Pleiades Publishing
3 publications, 5%
King Saud University
King Saud University, 2, 3.33%
King Saud University
2 publications, 3.33%
Future Medicine
Future Medicine, 1, 1.67%
Future Medicine
1 publication, 1.67%
Frontiers Media S.A.
Frontiers Media S.A., 1, 1.67%
Frontiers Media S.A.
1 publication, 1.67%
2
4
6
8
10
12
14
16
18
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Azzali E. et al. Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery // Journal of Medicinal Chemistry. 2017. Vol. 60. No. 16. pp. 7108-7122.
GOST all authors (up to 50) Copy
Azzali E., Machado D., Kaushik A. K., Vacondio F., Flisi S., Cabassi C. S., Lamichhane G., Viveiros M., Costantino G., Pieroni M. Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery // Journal of Medicinal Chemistry. 2017. Vol. 60. No. 16. pp. 7108-7122.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acs.jmedchem.7b00793
UR - https://doi.org/10.1021%2Facs.jmedchem.7b00793
TI - Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery
T2 - Journal of Medicinal Chemistry
AU - Costantino, Gabriele
AU - Azzali, Elisa
AU - Pieroni, Marco
AU - Machado, Diana
AU - Kaushik, Amit Kant
AU - Vacondio, Federica
AU - Flisi, Sara
AU - Cabassi, Clotilde Silvia
AU - Lamichhane, Gyanu
AU - Viveiros, Miguel
PY - 2017
DA - 2017/08/10 00:00:00
PB - American Chemical Society (ACS)
SP - 7108-7122
IS - 16
VL - 60
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Cite this
BibTex Copy
@article{2017_Azzali,
author = {Gabriele Costantino and Elisa Azzali and Marco Pieroni and Diana Machado and Amit Kant Kaushik and Federica Vacondio and Sara Flisi and Clotilde Silvia Cabassi and Gyanu Lamichhane and Miguel Viveiros},
title = {Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery},
journal = {Journal of Medicinal Chemistry},
year = {2017},
volume = {60},
publisher = {American Chemical Society (ACS)},
month = {aug},
url = {https://doi.org/10.1021%2Facs.jmedchem.7b00793},
number = {16},
pages = {7108--7122},
doi = {10.1021/acs.jmedchem.7b00793}
}
MLA
Cite this
MLA Copy
Azzali, Elisa, et al. “Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery.” Journal of Medicinal Chemistry, vol. 60, no. 16, Aug. 2017, pp. 7108-7122. https://doi.org/10.1021%2Facs.jmedchem.7b00793.
Found error?